Type 2 corticotropin-releasing hormone receptor mRNA expression in the heart in hypertensive rats

Life Sciences

Volumn 62, Issue 6, 1998, Pages 515-523

  Makino, Shinya ^a   Asaba, Koichi ^a   Takao, Toshihiro ^a   Hashimoto, Kozo ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Corticotropin releasing hormone; Deoxycorticosterone acetate; Heart; Receptor; SHR

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DEOXYCORTICOSTERONE ACETATE; MESSENGER RNA; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; HEART MUSCLE; HYPERTENSION; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SKELETAL MUSCLE; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; BLOOD PRESSURE; CORTICOTROPIN-RELEASING HORMONE; DESOXYCORTICOSTERONE; HYPERTENSION; MALE; MYOCARDIUM; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RNA, MESSENGER;

EID: 0032472361     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)01147-8     Document Type: Article

References (36)

1. 1. M. R. BROWN and L. A. FISHER, Corticotropin-releasing factor: basic and clinical studies of a neuropeptide, E. B. De Souza and C. B. Nemeroff (Eds), 291-298, CRC press, Boca Raton (1990).
2. 2. F. MENZAGHI, S. C. HEINRICHS, E. M. PICH, F. WEISS and G. F. KOOB, Ann. NY. Acad. Sci. 697 142-154 (1993).
3. 3. M. H. WHITNALL, Progress in Neurobiology 40 573-629 (1993).
4. 4. M. H. PERRIN, Y. HAAS, J. E. RIVIER and W. W. VALE, Endocrinology 118 1171-1179 (1986).
5. 5. M. H. PERRIN, C. J. DONALDSON, R. CHEN, K. A. LEWIS and W. W. VALE, Endocrinology 133 3058-3061 (1993).
6. 6. E. POTTER, S. SUTTON, C. DONALDSON, R. CHEN, M. PERRIN, K. LEWIS, P. E. SAWCHENKO and W. VALE, Proc. Natl. Acad. Sci. USA 91 8777-8781 (1994).
7. 7. T. W. LOVENBERG, C. W. LIAW, D. E. GRIGORIADIS, W. CLEVENGER, D. T. CHALMERS, E. B. DeSOUZA and T. OLTERSDORF, Proc. Natl. Acad. Sci. USA 92 36-840 (1995).
8. 8. P. STENZEL, R. KESTERSON, W. YEUNG, R. D. CONE, M. B. RITTENBERG and P. STENZEL-POORE, Mol. Endocrinol. 9 637-645 (1995).
9. 9. M. PERRIN, C. DONALDSON, R. CHEN, A. BLOUNT, T. BERGGREN, L. BILEZIKJIAN, P. E. SAWCHENKO and W. VALE, Proc. Natl. Acad. Sci. USA 92 2969-2973 (1995).
10. 10. T. KISHIMOTO, R. V. PEARSE II, C. R. LIN and M. G. ROSENFIELD, Proc. Natl. Acad. Sci. USA 92 1108-1112 (1995).
11. 11. R. CHEN, K. A. LEWIS, M. H. PERRIN and W. W. VALE, Proc. Natl. Acad. Sci. USA 90 8967-8971 (1993).
12. 12. J. VAUGHAN, C. DONALDSON, J. BITTENCOURT, M. H. PERRIN, K. LEWIS, S. SUTTON, R. CHEN, A. V. TURNBULL, D. LOVEJOY, C. RIVIER, J. RIVIER, P. E. SAWCHENKO and W. VALE, Nature 378 287-292 (1995).
13. 13. L. A. FISHER, G. JESSEN and M. R. BROWN, Regul. Pept, 5 153-161 (1983).
14. 14. M. R. BROWN and L. A. FISHER, Brain Res. 280 75-79 (1983).
15. 15. A. R. M. M. HERMUS, G. F. F. M. PIETERS, J. J. WILLEMSEN, H. A. ROSS, A. G. H. SMALS, T. J. BERNAAD and P. W. C. KLOPPENBORG, Eur. J. Clin. Pharmacol. 31 531-534 (1987).
16. 16. N. KALIN, S. SHELTON, G. KRAEMER and W. McKINNEY, Lancet 2 1042 (1982).
17. 17. D. ORTH, R. V. JACKSON, G. S. DeCHERNEY, C. R. DeBOLD, A. N. ALEXANDER, D. A. ISLAND, J. RIVIER, C. RIVIER, J. SPIESS, W. VALE, J. Clin. Invest. 71, 587-595 (1983).
18. 18. L. J. MUGLIA, N. A. JENKINS, D. J. GILBERT, N. G. COPELAND and J. A. MAJOZOUB, J. Clin. Invest. 93 2066-2072 (1994).
19. 19. S. MAKINO, J. SCHULKIN, M. A. SMITH, K. PACAK, M. PALKOVITZ and P. W. GOLD, Endocrinology 136 4517-4525 (1995).
20. 20. D. T. CHALMERS, T. W. LOVENBERG and E. B. DeSOUZA, J. Neurosci. 15 6340-6350 (1995).
21. 21. R. L. HAUGER and G. AGUILERA, Endocrinology 133 1708-1714 (1993).
22. 22. G. POZZOLI, L. M. BILEZIKJIAN, M. H. PERRIN, A. L. BLOUNT and W. W. VALE, Endocrinology 137 65-71 (1996).
23. 23. M. GRUNT, J. GLASER, H. SCHMIDHUBER, P. PAUSCHINGER and J. BORN, Am. J. Physiol. 264 H1124-H1129 (1993).
24. 24. S. SUEMARU, K. HASHIMOTO, T. HATTORI, H. INOUE, J. KAGEYAMA and Z. OTA, Life Sci. 39 1161-1166 (1986).
25. 25. K. HASHIMOTO, T. HATTORI, K. MURAKAMI, S. SUEMARU, Y. KAWADA, J. KAGEYAMA and Z. OTA Life Sci. 36 643-647 (1985).
26. 26. R. J. REID, J. A. ZIVIN and I. J. KOPIN Circ. Res. 37 569-579 (1975).
27. 27. T. C. WESTFALL and M. J. MELDRUM Ann. Rev. Pharmacol. Toxicol. 25 621-641 (1985).
28. 28. P. B. M. W. M. TIMMERMANS, P. C. WONG, A. T. CHIU, W. F. HERBLIN, P. BENFIELD, D. J. CARINI, R. J. LEE, R. R. WEXLER, J. M. SAYE and R. D. SMITH, Pharmacol. Rev. 45 205-251 (1993).
29. 29. R. LARIVIERE, G. THIBAULT and E. L. SCHIFFRIN, Hypertension 21 294-300 (1993).
30. 30. R. LARIVIERE, R. DAY and L. SCHIFFRIN, Hypertension 21 916-920 (1993).
31. 31. R. LARIVIERE, P. SVENTEK and E. L. SCHIFFRIN, Life Sci. 56 1889-1896 (1995).
32. 32. E. L. SCHIFFRIN, P. SVENTEK, J.-S. LI, A. TURGEON and T. REUDELHUBER, Br. J. Pharmacol. 115 1377-1381 (1995).
33. 33. K. A. HELDWEIN, D. L. REDICK, M. B. PITTENBERG, W. C. CLAYCOMB and M. P. STENZEL-POORE Endocrinology 137 3631-3639 (1996).
34. 34. M. SAITOH, H. HASEGAWA and H. MASHIBA, Gen. Pharmacol. 21 337-342 (1990).
35. 35. M. GRUNT, C. HAUG, L. DUNTAS, P. PAUSCHINGER, V. MAIER and E. F. PFEIFFER, Horm. Metab. Res. 24 56-59 (1992).
36. 36. K. TOJO, S. SATO, G. TOKUDOME, M. OHTA, Y. KAWAGUCHI, O. SAKAI, O. NAKAGAWA, K. NAKAO, (abstract) 10th International Congress of Endocrinology, San Francisco, CA, P3-511 (1996).